Found: 14
Select item for more details and to access through your institution.
Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of Escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 7, p. 1015, doi. 10.1038/sj.cgt.7700189
- By:
- Publication type:
- Article
Rabbit cytochrome P450 4B1: A novel prodrug activating gene for pharmacogene therapy of hepatocellular carcinoma.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 7, p. 1008, doi. 10.1038/sj.cgt.7700190
- By:
- Publication type:
- Article
Adenovirus-mediated N5 gene transfer inhibits tumor cell proliferation by induction of apoptosis.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 7, p. 985, doi. 10.1038/sj.cgt.7700194
- By:
- Publication type:
- Article
Combinational immunotherapy for established tumors with engineered tumor vaccines and adenovirus-mediated gene transfer.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 7, p. 1023, doi. 10.1038/sj.cgt.7700195
- By:
- Publication type:
- Article
Targeting and eradicating cancer cells by a prostate-specific vector carrying the diphtheria toxin A gene.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 7, p. 991, doi. 10.1038/sj.cgt.7700197
- By:
- Publication type:
- Article
Impact of liver P450 reductase suppression on cyclophosphamide activation, pharmacokinetics and antitumoral activity in a cytochrome P450-based cancer gene therapy model.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 7, p. 1034, doi. 10.1038/sj.cgt.7700200
- By:
- Publication type:
- Article
Interleukin-12 (IL-12) gene therapy of leukemia: Immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cells.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 7, p. 1060, doi. 10.1038/sj.cgt.7700201
- By:
- Publication type:
- Article
Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 7, p. 997, doi. 10.1038/sj.cgt.7700202
- By:
- Publication type:
- Article
Increased non-major histocompatibility complex-restricted lytic activity in melanoma patients vaccinated with cytokine gene-transfected autologous tumor cells.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 7, p. 976, doi. 10.1038/sj.cgt.7700203
- By:
- Publication type:
- Article
Transformation-defective adenovirus 5 E1A mutants exhibit antioncogenic properties in human BLM melanoma cells.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 7, p. 1043, doi. 10.1038/sj.cgt.7700206
- By:
- Publication type:
- Article
Cytotoxicity, apoptosis, and viral replication in tumor cells treated with oncolytic ribonucleotide reductase-defective herpes simplex type 1 virus (hrR3) combined with ionizing radiation.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 7, p. 1051, doi. 10.1038/sj.cgt.7700208
- By:
- Publication type:
- Article
A herpesvirus saimiri-based gene therapy vector with potential for use in cancer immunotherapy.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 7, p. 1077, doi. 10.1038/sj.cgt.7700210
- By:
- Publication type:
- Article
Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 7, p. 1069, doi. 10.1038/sj.cgt.7700214
- By:
- Publication type:
- Article
Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model.
- Published in:
- Cancer Gene Therapy, 2000, v. 7, n. 7, p. 1086, doi. 10.1038/sj.cgt.7700215
- By:
- Publication type:
- Article